Ice­landic bil­lionare's biosim­i­lar com­pa­ny rais­es $450M, preps for Nas­daq launch with SPAC merg­er

As Ice­landic bil­lion­aire Róbert Wess­man tries to take down Ab­b­Vie’s megablock­buster Hu­mi­ra in court, he’s al­so tak­ing his biosim­i­lar up­start to the big time with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER